Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Reactogenicity of Boostrix in Healthy Adults
NCT01267058Phase 3Completed
- Sponsor
- GSK
- Start
- Sep 1997
- Primary completion
- Feb 1998
- Modality
- Vaccines & Immunotherapeutics
01
Overview
A Phase 3 trial of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) in diphtheria, Tetanus, pertussis, sponsored by GSK. Started Sep 1997; status: completed.
02
Drugs
Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)
03
Conditions
diphtheriaTetanuspertussis
Beyond the preview
Go deeper on NCT01267058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01267058.